What Does a 252 Cholesterol Level Mean for Your Health?

A total cholesterol reading of 252 mg/dL falls into the “high” category under longstanding U.S. guidelines, which classify anything above 240 mg/dL as elevated, 200–239 mg/dL as borderline, and below 200 mg/dL as desirable.¹ That said, the number 252 by itself is a starting point, not a verdict. What it actually means for your heart depends on which lipoproteins are driving the total upward, what your other risk factors look like, and whether the reading reflects a treatable underlying cause.

Why the Total Number Only Tells Part of the Story

Total cholesterol is the sum of several components: LDL (the type most directly linked to artery damage), HDL (which helps remove cholesterol from artery walls), and other particles including VLDL and remnant lipoproteins. Two people can both read 252 and face very different levels of risk. If your HDL is unusually high, say 85 mg/dL, your LDL might be perfectly reasonable. If your HDL is low and triglycerides are elevated, the same total of 252 could signal a much more dangerous lipid profile.

That is why doctors rarely act on total cholesterol alone. A standard lipid panel breaks the number down, and modern risk assessment increasingly favors non-HDL cholesterol and a protein called apolipoprotein B (apoB) over LDL cholesterol by itself. Non-HDL cholesterol captures the cholesterol carried by all the particles that contribute to plaque buildup, not just LDL. A large meta-analysis found that apoB outperformed both LDL and non-HDL cholesterol as a predictor of cardiovascular events, while LDL cholesterol was the weakest of the three markers.² In practical terms, apoB gives the most accurate count of how many artery-clogging particles are actually circulating, especially in people with diabetes, obesity, or mildly elevated triglycerides.³

Population-level data reinforce this. In a large study examining subclinical atherosclerosis, people with high apoB or high non-HDL cholesterol had thicker artery walls, more plaques, and stiffer blood vessels. Sorting people by LDL cholesterol alone produced much less clear differences in those same markers.⁴ So if your lab results show a total of 252, the follow-up conversation with your doctor should focus less on that headline number and more on how the subfraction breakdown looks.

What Happens Inside Your Arteries When Cholesterol Is Elevated

High cholesterol matters because of what excess LDL particles do once they cross into artery walls. LDL that gets trapped in the vessel lining becomes chemically modified, particularly through oxidation. Immune cells called macrophages rush in to clean up these damaged particles, but the cleanup goes wrong. The macrophages gorge on oxidized LDL and swell into what researchers call “foam cells,” which are a hallmark of early plaque development.⁵ The process relies on specific surface receptors on the macrophages, particularly a protein called CD36, which works together with an enzyme called PLD2 to pull in aggregated oxidized LDL.⁶

This is not a one-time event. Even brief exposure to oxidized LDL can reprogram monocytes (the precursors of macrophages) into a long-lasting pro-inflammatory state. These reprogrammed cells ramp up production of inflammatory signals and become even more efficient at forming foam cells, which feeds a cycle of plaque growth.⁷ The more LDL particles in circulation, the more raw material there is for this cycle. That is the core reason elevated LDL raises heart disease risk over time, and why a reading like 252 warrants figuring out how much of that total is LDL-driven.

How Doctors Evaluate Your Actual Risk

A 252 total cholesterol in a 30-year-old nonsmoker with high HDL and no family history of heart disease is a completely different situation from 252 in a 60-year-old with diabetes and high blood pressure. Risk calculators used in clinical practice, such as the ASCVD Risk Estimator, weigh your cholesterol numbers alongside age, sex, race, blood pressure, whether you smoke, and whether you have diabetes.⁸ The output is a percentage representing your estimated chance of having a major cardiovascular event over the next ten years. That percentage, not the cholesterol number in isolation, drives treatment decisions.

These calculators are imperfect, though. Research has shown they can overestimate risk in some populations, particularly when applied to ethnic groups that were underrepresented in the original data used to build the equations.⁹ For people who fall in the borderline or intermediate-risk zone, where a cholesterol of 252 could easily land you, a coronary artery calcium (CAC) scan can sharpen the picture. This imaging test measures actual calcium deposits in your coronary arteries, a direct marker of plaque buildup. Adding a CAC score to the standard risk calculator reclassified about a quarter of patients into a different risk category in one major study.¹⁰

Professional guidelines now suggest that a CAC scan can be useful specifically for people in that uncertain middle ground, helping decide whether statin therapy is warranted or can safely be postponed.¹¹ A calcium score of zero, for instance, generally indicates low short-term risk, which could mean someone with a total cholesterol of 252 and no other red flags might reasonably focus on lifestyle changes and recheck later rather than starting medication immediately.¹²

What Could Be Driving a Reading of 252

Before assuming your cholesterol is high because of your diet or bad luck, it is worth considering whether something else is pulling it up. Hypothyroidism is the most common medical condition that raises cholesterol after dietary factors are accounted for.¹³ An underactive thyroid slows the clearance of LDL from the bloodstream, and the resulting lipid pattern tends to be atherogenic. The good news is that treating the thyroid problem typically brings cholesterol back down.¹⁴ Other medical conditions including diabetes, metabolic syndrome, and kidney dysfunction can also push cholesterol upward, as can certain medications. Screening for these secondary causes is part of the standard workup when someone presents with newly elevated cholesterol.

Genetics play a significant role as well. Familial hypercholesterolemia (FH) is a well-known inherited condition that leads to very high LDL from a young age, but most people with elevated cholesterol do not have FH in its classic single-gene form. Research now shows that in over 80% of patients who meet the clinical criteria for FH but carry no identifiable single-gene mutation, a “polygenic” explanation is the most likely cause. This means the elevated cholesterol results from inheriting a greater-than-average number of common gene variants that each nudge LDL upward by a small amount.¹⁵ For someone with a total cholesterol of 252, the cause is often some combination of these genetic influences, lifestyle factors, and possibly an unrecognized secondary condition.

Menopause and Cholesterol Shifts

If you are a woman in your late forties or fifties and your cholesterol has recently climbed toward or past 252, the timing might not be coincidental. Cholesterol tends to rise in both sexes with age, but in women there is a distinct surge tied to the menopause transition. One long-running study found that total cholesterol began increasing about three years before natural menopause, with the steepest rise occurring between that point and one year after the final menstrual period.¹⁶ In women undergoing surgical menopause (such as after removal of the ovaries), the cholesterol jump happens at the time of surgery itself.

The magnitude of this change is real. Research tracking women through the transition found that total cholesterol, LDL, and triglycerides peaked during late perimenopause and early postmenopause. The odds of having LDL above 130 mg/dL roughly doubled for early postmenopausal women compared to premenopausal women of the same age.¹⁷ Metabolic profiling of postmenopausal women confirms they carry higher concentrations of total cholesterol, LDL of all particle sizes, and apoB compared to premenopausal women.¹⁸ This means a reading of 252 in a recently menopausal woman might partly reflect a hormonal shift rather than a long-term lipid problem, though the cardiovascular implications still need to be managed.

Lifestyle Changes and How Much They Can Move the Needle

For someone at 252, lifestyle modification is almost always the first recommendation, and sometimes the only one needed. The dietary changes with the strongest evidence behind them focus less on avoiding cholesterol-rich foods and more on swapping out what kind of fat you eat, and on increasing soluble fiber. A systematic review of accumulated evidence found that foods high in unsaturated fats and low in saturated and trans fats, foods with added plant sterols or stanols, and high-soluble-fiber sources like oats, barley, and psyllium each produced at least moderate LDL reductions.¹⁹ “Moderate” in clinical terms means an LDL drop in the range of about 8 to 15 mg/dL, which is meaningful but might not be enough on its own to bring someone from 252 total cholesterol down below the desirable threshold.

Exercise contributes too, though its biggest lipid effect is often on HDL rather than on LDL directly. Aerobic activity is generally associated with higher HDL and lower LDL and triglycerides.²⁰ The HDL-raising benefit appears strongest in people who start out with elevated triglycerides and abdominal obesity. In the HERITAGE study, men with both high triglycerides and low HDL saw about a 5% increase in HDL cholesterol after a 20-week endurance exercise program, while men with isolated low HDL saw no significant change.²¹ In other words, exercise is most helpful for reshaping an unfavorable lipid profile when it is part of broader metabolic improvement, including losing visceral fat.

One misconception worth addressing: the cholesterol you eat has less impact on blood cholesterol than most people assume. Research on premenopausal women, for instance, showed that even a high-cholesterol dietary challenge did not significantly alter the LDL-to-HDL ratio.²² The body adjusts its own cholesterol production in response to intake, and for most people the regulation is effective enough that cutting eggs or shrimp makes a much smaller difference than reducing saturated fat or increasing fiber.

When Medication Enters the Picture

If lifestyle changes are not enough, or if your overall cardiovascular risk profile is already concerning, medications become part of the conversation. Statins remain the first-line treatment. They work by blocking an enzyme involved in cholesterol production in the liver, and beyond lowering LDL they offer other cardiovascular benefits including reducing inflammation, improving blood vessel function, and stabilizing existing plaques. A meta-analysis of imaging-based studies found that high-intensity statin therapy was the most effective lipid-lowering approach at actually shrinking coronary plaque volume.²³ That is a remarkable finding, because it means the damage from elevated cholesterol is not always permanent.

For people who need more than a statin alone, or who cannot tolerate statins, other options exist. Ezetimibe blocks cholesterol absorption in the gut and can be added to a statin. PCSK9 inhibitors are injectable drugs that dramatically lower LDL by helping the liver clear more LDL particles from the blood. In patients with familial hypercholesterolemia already on high-intensity statins, adding a PCSK9 inhibitor cut LDL by about half and also reduced arterial stiffness significantly more than adding ezetimibe did.²⁴ Guidelines suggest that adding a second lipid-lowering drug to statins makes sense for people at very high or high cardiovascular risk, but probably not for those at low risk.²⁵

Do You Need to Fast Before Testing?

If you got your 252 reading from a nonfasting blood draw and wonder whether it is accurate, the answer is that it is probably close enough. A joint consensus statement from major European medical societies concluded that nonfasting lipid profiles are clinically acceptable for routine screening. The maximum average shift from eating is modest: total cholesterol drops by about 8 mg/dL after a meal, while triglycerides rise by about 26 mg/dL. HDL and apoB are essentially unaffected by eating.²⁶ So a nonfasting total cholesterol of 252 might be about 260 fasting, or could be the same either way. The difference is small enough that it would not change the clinical category or the overall management approach.

One situation where fasting still matters is when triglycerides are the main concern. Because triglycerides can swing more noticeably after a meal, a doctor may request a fasting recheck if your triglyceride level looks borderline or high on a nonfasting draw.²⁷ But for total cholesterol, LDL, and HDL, fasting and nonfasting results predict cardiovascular risk about equally well.

Lipoprotein(a) and Hidden Risk

There is one risk factor that standard lipid panels do not capture and that no amount of diet or exercise will fix. Lipoprotein(a), often written as Lp(a), is a type of LDL-like particle whose blood level is almost entirely determined by genetics. The American Heart Association has recognized elevated Lp(a) as an independent, genetically determined cause of atherosclerotic cardiovascular disease, acting through mechanisms tied to plaque buildup, inflammation, and blood clotting.²⁸ Roughly one in five people has an elevated level, and it remains a risk factor even when LDL has been brought down to target with treatment.²⁹

Lp(a) is worth mentioning here because someone with a total cholesterol of 252 and an elevated Lp(a) carries more risk than the standard numbers suggest. Lp(a) is not routinely measured on a basic lipid panel, so you would need to specifically ask for it. It only needs to be checked once in a lifetime since the level is genetically fixed. There are no approved drugs specifically targeting Lp(a) on the market yet, though several are in late-stage clinical trials. Knowing your level matters mainly because it changes how aggressively your other risk factors should be managed.